Developer docs
API playgroundTry for free, no card

Search company profiles

Roslin Technologies

Full company profile

uuid00022im

Namestring
Roslin Technologies
Legal namestring
Roslin Technologies Limited
Websiteurl
roslintech.com
Company typeenum
Private
Founded yearint
2016
Short descriptiontext

Roslin Technologies is a UK biotechnology company that develops and supplies pluripotent animal stem cell lines (iPSC and ESC) and scale-up media/protocols to cultivated meat producers globally, and applies the same platform to animal health partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEdinburgh, United Kingdom
HQ citystring
Edinburgh
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
animal stem cells, cultivated meat inputs, cell line development, bioprocess scale-up, cellular agriculture
Industry2 codes
PRIMARYAFANAKAE
Cell Line Development & Banking (Food/AG Cell Lines)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)
SECONDARYAFANAKAC
Cultivated Meat Producers (Cell-Cultured Meat & Seafood)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)
NAICS code2 codes
  • Other Animal Production1129
  • Animal Slaughtering and Processing31161
SIC code1 code
  • Meat Packing Plants2011
Product category
Cultivated Meat Cell Lines
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Cell line product sales (B2B)
TypeHardware Sales
Description

Sale of proprietary animal stem cell lines (Porcine iPSC, Bovine ESC, Ovine iPSC, Ovine ESC) as off-the-shelf catalog products in standard or suspension-adapted vials shipped on dry ice to cultivated meat producers worldwide.

roslintech.com
2Scale-up packages and supporting products
TypeProfessional Services
Description

Revenue from bundled cell line plus food-safe growth media, differentiation protocols and technical transfer, enabling customers to scale production.

roslintech.com
3Custom / tail-ended cell line development and licensing
TypeLicensing Royalties
Description

Joint development of new cell lines with customers and development collaborators; licensing and commercialisation of intellectual property from University of Edinburgh's Royal (Dick) School of Veterinary Studies and the Roslin Institute. New species (e.g., Bovine iPSC, Salmon) being developed.

roslintech.com
4Animal health / veterinary cell line development partnerships
TypeLicensing Royalties
Description

Commercial partnerships such as the Likarda canine iPS cell line collaboration, applying the same stem cell platform to animal therapeutics.

roslintech.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Enquiry-based pricing for cell line products and scale-up packages; catalog sizes in standard or suspension-adapted vials.
ModelOther
Notes

Pricing not publicly disclosed; quotes provided on request via the company's contact form. Product formats defined by cell count (e.g., 1 x 10^6 or 25 x 10^6 cells per vial).

roslintech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Roslin Technologies develops and supplies animal stem cell lines (porcine iPSC, bovine ESC, ovine iPSC, ovine ESC, plus bovine iPSC and salmon lines in development) for cultivated meat producers. Its commercial offering bundles the cell lines with scale-up and differentiation packages, food-safe media, cell banking and characterization services, and regulatory support, sold primarily to other cellular agriculture businesses developing cell-cultivated meat products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 61% reduction in cell culture media cost via University of Edinburgh / IBioIC collaboration
+3 more records
Product overview1 text field

Roslin Technologies operates a single-platform cell line business targeting the cultivated meat industry, centred on pluripotent animal stem cell derivation and supply. The portfolio is unified around iPSC and ESC technologies across multiple species: the core, commercially available offerings are Porcine iPSC, Bovine ESC, Ovine iPSC and Ovine ESC, complemented by Bovine iPSC and Salmon cell lines in development. These cell line products are bundled with supporting scale-up and differentiation packages, food-safe cell culture media, cell banking and characterisation services, and tailored customer support including training and data for novel food regulatory dossiers, allowing cultivated meat producers to bring products to market faster with lower cost and risk.

Product and service1 record
1Porcine iPSC line
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

Israeli cultured meat startup completing the first phase of a cross-platform partnership using Roslin Technologies' growth medium to culture cells. Demonstrates platform flexibility, consistency and potential for cost reduction, supporting broader biomanufacturing ambitions including medical and cosmetics industries.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-06-16
Description

Growth media partner in an industry collaboration highlighted in Protein Production Technology International as accelerating cultivated meat development. Forms part of a plug-and-play collaboration ecosystem with Roslin Technologies and The Cultured Hub.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-06-16
Description

Bioprocessing partner in the Multus-Roslin Tech-Cultured Hub collaboration ecosystem featured in Protein Production Technology International as an example of plug-and-play framework fostering innovation and faster cultivated meat commercialisation.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-10-13
Description

Supported a project with the University of Edinburgh that developed a new approach to cell generation, eliminating batch-to-batch variation, cutting cell culture media cost by 61%, and demonstrating scale-up from 500 mL to 5 L bioreactor (target 2,000 L).

5University of Edinburgh (Roslin Institute)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2022-10-13
Description

Co-developed with Roslin Technologies (and IBioIC) a new approach to cell generation that cuts cell culture media cost by 61% and demonstrates bioreactor scale-up. University provides privileged access to expertise and intellectual property.

roslintech.com
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2020-07-30
Description

Extended commercial partnership on canine iPS cell lines for companion animal regenerative medicine (e.g., diabetes in dogs). Likarda is a leading regenerative medicine company for companion animals.

7University of Edinburgh
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2017-01-01
Description

Roslin Technologies was founded in 2017 as a venture between two investment firms and the University of Edinburgh; the company holds certain rights to commercialise intellectual property from the University's Royal (Dick) School of Veterinary Studies and the Roslin Institute, a global leader in animal science. Prof Catherine Martin is Vice Principal of Corporate Services at the University.

roslintech.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Multus is a UK-based cultivated meat startup that produces growth media and recombinant proteins used by cultivated meat producers. Both Roslin Technologies and Multus supply critical upstream inputs (cells and media respectively) to the same cultivated meat customer base, and they are positioned as complementary partners in the same plug-and-play ecosystem.

TypeDirect peer
Description

The Cultured Hub is a Singapore-based bioprocess and scale-up services provider for cultivated meat companies, co-located with A*STAR and other Singapore foodtech players. Both firms sit in the cultivated meat B2B enablement layer, providing scale-up capabilities that complement Roslin's cell line supply to the same producer customers.

TypeEmerging player
Description

Aleph Farms is an Israeli cultivated meat company producing cell-cultivated beef steaks. As both a Roslin customer and an emerging player in the same cultivated meat category, it provides both commercial validation and a potential example of vertical integration that could compete with Roslin in the future.

TypeEmerging player
Description

Mosa Meat is a Dutch cultivated beef company and one of the category pioneers (spun out of Maastricht University in 2013). It is comparable to Roslin Technologies as a cultivated meat innovator targeting the same beef end-market, though Mosa Meat is a producer while Roslin supplies upstream cell technology.

TypeEmerging player
Description

Meatable is a Dutch cultivated meat startup developing pork and beef using iPSC technology with proprietary single-step differentiation. It directly parallels Roslin Technologies' iPSC platform approach; Roslin's VP Development Jef Pinxteren previously worked at Meatable on scale-up, underlining the technical overlap.

TypeEmerging player
Description

Upside Foods (formerly Memphis Meats) is a US cultivated meat leader producing cell-cultivated chicken, beef and duck. Comparable as a cultivated meat pioneer with proprietary cell line capabilities; represents both a potential customer and a future vertical competitor to Roslin's cell line supply model.

TypeEmerging player
Description

BlueNalu is a US cultivated seafood company developing cell-cultivated fish products. Comparable to Roslin's seafood expansion ambitions (Roslin has a salmon cell line in development), and represents both a potential customer and a peer in defining the cultivated meat/cultivated seafood category.

TypeEmerging player
Description

Eat Just's GOOD Meat division is one of the first cultivated meat businesses to receive regulatory approval and reach consumers (Singapore). Comparable to Roslin as a cultivated meat category pioneer and potential customer for animal cell lines, with the additional strategic significance of having navigated novel food regulatory pathways.

TypeBroad incumbent
Description

Fujifilm Cellular Dynamics International is a leading commercial iPSC provider focused on human cell applications (drug discovery, cell therapy, toxicology). Comparable to Roslin as a pioneer commercial iPSC platform company; Roslin's CSO Deepika Rajesh previously led R&D at CDI, and CDI's expertise and IP base provide an indirect benchmark for animal iPSC commercialisation.

TypeBroad incumbent
Description

Bio-Techne is a large US life sciences tools company supplying cell culture reagents, media, and stem cell research products globally. Comparable as a supplier of inputs into the stem cell and cell therapy ecosystem in which Roslin operates, with significantly broader portfolio scale but less specialisation in cultivated meat-specific animal iPSC/ESC lines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Roslin Technologies

Cultivated Meat Cell Linesroslintech.com

Roslin Technologies is a UK biotechnology company that develops and supplies pluripotent animal stem cell lines (iPSC and ESC) and scale-up media/protocols to cultivated meat producers globally, and applies the same platform to animal health partnerships.

Roslin Technologies firmographics

Firmographics
Name
Roslin Technologies
Legal name
Roslin Technologies Limited
Website
https://roslintech.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Roslin Technologies is a UK biotechnology company that develops and supplies pluripotent animal stem cell lines (iPSC and ESC) and scale-up media/protocols to cultivated meat producers globally, and applies the same platform to animal health partnerships.
Ownership category
akta.pro rank

Roslin Technologies industry classification

Industry
Product category
Cultivated Meat Cell Lines
NAICS
Other Animal Production (1129), Animal Slaughtering and Processing (31161)
SIC
Meat Packing Plants (2011)
akta.pro industry
PRIMARYAFANAKAE
Cell Line Development & Banking (Food/AG Cell Lines)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)
SECONDARYAFANAKAC
Cultivated Meat Producers (Cell-Cultured Meat & Seafood)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)

Keywords

  • Animal stem cells
  • Cultivated meat inputs
  • Cell line development
  • Bioprocess scale-up
  • Cellular agriculture

Where Roslin Technologies is headquartered

Location

Headquarters

HQ city
Edinburgh
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Roslin Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Cell line product sales (B2B): Sale of proprietary animal stem cell lines (Porcine iPSC, Bovine ESC, Ovine iPSC, Ovine ESC) as off-the-shelf catalog products in standard or suspension-adapted vials shipped on dry ice to cultivated meat producers worldwide.
  2. Scale-up packages and supporting products: Revenue from bundled cell line plus food-safe growth media, differentiation protocols and technical transfer, enabling customers to scale production.
  3. Custom / tail-ended cell line development and licensing: Joint development of new cell lines with customers and development collaborators; licensing and commercialisation of intellectual property from University of Edinburgh's Royal (Dick) School of Veterinary Studies and the Roslin Institute. New species (e.g., Bovine iPSC, Salmon) being developed.
  4. Animal health / veterinary cell line development partnerships: Commercial partnerships such as the Likarda canine iPS cell line collaboration, applying the same stem cell platform to animal therapeutics.

Pricing tiers

ModelBillingPrice
Other—Enquiry-based pricing for cell line products and scale-up packages; catalog sizes in standard or suspension-adapted vials.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Roslin Technologies product offering

Product offering

Core offering

Roslin Technologies develops and supplies animal stem cell lines (porcine iPSC, bovine ESC, ovine iPSC, ovine ESC, plus bovine iPSC and salmon lines in development) for cultivated meat producers. Its commercial offering bundles the cell lines with scale-up and differentiation packages, food-safe media, cell banking and characterization services, and regulatory support, sold primarily to other cellular agriculture businesses developing cell-cultivated meat products.

Product overview

Roslin Technologies operates a single-platform cell line business targeting the cultivated meat industry, centred on pluripotent animal stem cell derivation and supply. The portfolio is unified around iPSC and ESC technologies across multiple species: the core, commercially available offerings are Porcine iPSC, Bovine ESC, Ovine iPSC and Ovine ESC, complemented by Bovine iPSC and Salmon cell lines in development. These cell line products are bundled with supporting scale-up and differentiation packages, food-safe cell culture media, cell banking and characterisation services, and tailored customer support including training and data for novel food regulatory dossiers, allowing cultivated meat producers to bring products to market faster with lower cost and risk.

Differentiator

Problem solved

Functional benefit

Products and services

  • Porcine iPSC line

Quantifiable outcome

  • 61% reduction in cell culture media cost via University of Edinburgh / IBioIC collaboration
  • +3 more outcomes

Companies that use Roslin Technologies

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Roslin Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Roslin Technologies partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered major and flagship.

  • Aleph FarmsmajorStrategic or Co-development Partner · 11 February 2026Israeli cultured meat startup completing the first phase of a cross-platform partnership using Roslin Technologies' growth medium to culture cells. Demonstrates platform flexibility, consistency and potential for cost reduction, supporting broader biomanufacturing ambitions including medical and cosmetics industries.
  • MultusmajorStrategic or Co-development Partner · 16 June 2025Growth media partner in an industry collaboration highlighted in Protein Production Technology International as accelerating cultivated meat development. Forms part of a plug-and-play collaboration ecosystem with Roslin Technologies and The Cultured Hub.
  • The Cultured HubmajorStrategic or Co-development Partner · 16 June 2025Bioprocessing partner in the Multus-Roslin Tech-Cultured Hub collaboration ecosystem featured in Protein Production Technology International as an example of plug-and-play framework fostering innovation and faster cultivated meat commercialisation.
  • Industrial Biotechnology Innovation Centre (IBioIC)majorStrategic or Co-development Partner · 13 October 2022Supported a project with the University of Edinburgh that developed a new approach to cell generation, eliminating batch-to-batch variation, cutting cell culture media cost by 61%, and demonstrating scale-up from 500 mL to 5 L bioreactor (target 2,000 L).
  • University of Edinburgh (Roslin Institute)flagshipStrategic or Co-development Partner · 13 October 2022Co-developed with Roslin Technologies (and IBioIC) a new approach to cell generation that cuts cell culture media cost by 61% and demonstrates bioreactor scale-up. University provides privileged access to expertise and intellectual property.
  • LikardamajorStrategic or Co-development Partner · 30 July 2020Extended commercial partnership on canine iPS cell lines for companion animal regenerative medicine (e.g., diabetes in dogs). Likarda is a leading regenerative medicine company for companion animals.
  • University of EdinburghflagshipStrategic or Co-development Partner · 1 January 2017Roslin Technologies was founded in 2017 as a venture between two investment firms and the University of Edinburgh; the company holds certain rights to commercialise intellectual property from the University's Royal (Dick) School of Veterinary Studies and the Roslin Institute, a global leader in animal science. Prof Catherine Martin is Vice Principal of Corporate Services at the University.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Roslin Technologies competitors and assessment

Company assessment

Direct peers

  • Multus: Multus is a UK-based cultivated meat startup that produces growth media and recombinant proteins used by cultivated meat producers. Both Roslin Technologies and Multus supply critical upstream inputs (cells and media respectively) to the same cultivated meat customer base, and they are positioned as complementary partners in the same plug-and-play ecosystem.
  • The Cultured Hub: The Cultured Hub is a Singapore-based bioprocess and scale-up services provider for cultivated meat companies, co-located with A*STAR and other Singapore foodtech players. Both firms sit in the cultivated meat B2B enablement layer, providing scale-up capabilities that complement Roslin's cell line supply to the same producer customers.

Emerging players

  • Aleph Farms: Aleph Farms is an Israeli cultivated meat company producing cell-cultivated beef steaks. As both a Roslin customer and an emerging player in the same cultivated meat category, it provides both commercial validation and a potential example of vertical integration that could compete with Roslin in the future.
  • Mosa Meat: Mosa Meat is a Dutch cultivated beef company and one of the category pioneers (spun out of Maastricht University in 2013). It is comparable to Roslin Technologies as a cultivated meat innovator targeting the same beef end-market, though Mosa Meat is a producer while Roslin supplies upstream cell technology.
  • Meatable: Meatable is a Dutch cultivated meat startup developing pork and beef using iPSC technology with proprietary single-step differentiation. It directly parallels Roslin Technologies' iPSC platform approach; Roslin's VP Development Jef Pinxteren previously worked at Meatable on scale-up, underlining the technical overlap.
  • Upside Foods: Upside Foods (formerly Memphis Meats) is a US cultivated meat leader producing cell-cultivated chicken, beef and duck. Comparable as a cultivated meat pioneer with proprietary cell line capabilities; represents both a potential customer and a future vertical competitor to Roslin's cell line supply model.
  • BlueNalu: BlueNalu is a US cultivated seafood company developing cell-cultivated fish products. Comparable to Roslin's seafood expansion ambitions (Roslin has a salmon cell line in development), and represents both a potential customer and a peer in defining the cultivated meat/cultivated seafood category.
  • Eat Just (GOOD Meat): Eat Just's GOOD Meat division is one of the first cultivated meat businesses to receive regulatory approval and reach consumers (Singapore). Comparable to Roslin as a cultivated meat category pioneer and potential customer for animal cell lines, with the additional strategic significance of having navigated novel food regulatory pathways.

Broad incumbents

  • Cellular Dynamics International (Fujifilm CDI): Fujifilm Cellular Dynamics International is a leading commercial iPSC provider focused on human cell applications (drug discovery, cell therapy, toxicology). Comparable to Roslin as a pioneer commercial iPSC platform company; Roslin's CSO Deepika Rajesh previously led R&D at CDI, and CDI's expertise and IP base provide an indirect benchmark for animal iPSC commercialisation.
  • Bio-Techne: Bio-Techne is a large US life sciences tools company supplying cell culture reagents, media, and stem cell research products globally. Comparable as a supplier of inputs into the stem cell and cell therapy ecosystem in which Roslin operates, with significantly broader portfolio scale but less specialisation in cultivated meat-specific animal iPSC/ESC lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

Roslin Technologies social profiles

Digital presence

Roslin Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Roslin Technologies leadership team

Management profile

Number of profiles

Roslin Technologies funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Roslin Technologies M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roslin Technologies

What does Roslin Technologies do?

Roslin Technologies develops and supplies animal stem cell lines (porcine iPSC, bovine ESC, ovine iPSC, ovine ESC, plus bovine iPSC and salmon lines in development) for cultivated meat producers. Its commercial offering bundles the cell lines with scale-up and differentiation packages, food-safe media, cell banking and characterization services, and regulatory support, sold primarily to other cellular agriculture businesses developing cell-cultivated meat products.

Is Roslin Technologies a public or private company?

Roslin Technologies is a private company. It is classified as venture growth investor backed and is currently operating.

When was Roslin Technologies founded?

Roslin Technologies was founded in 2016. It employs 11 to 50 people.

Where is Roslin Technologies based?

Roslin Technologies is headquartered in Edinburgh, United Kingdom, in the Europe region.

How does Roslin Technologies make money?

Four revenue lines are on record. Cell line product sales (B2B) is the primary driver. The others are scale-up packages and supporting products, custom / tail-ended cell line development and licensing and animal health / veterinary cell line development partnerships.

Who are Roslin Technologies's main competitors?

Direct peers on record are Multus and The Cultured Hub. Emerging players are Aleph Farms, Mosa Meat, Meatable, Upside Foods, BlueNalu and Eat Just (GOOD Meat). Broad incumbents are Cellular Dynamics International (Fujifilm CDI) and Bio-Techne.

Does Roslin Technologies have an API?

No public API is recorded for Roslin Technologies.

What industry is Roslin Technologies in?

Roslin Technologies's product category is Cultivated Meat Cell Lines. Its primary akta.pro industry code is AFANAKAE, Cell Line Development & Banking (Food/AG Cell Lines), with a secondary code of AFANAKAC, Cultivated Meat Producers (Cell-Cultured Meat & Seafood). Its NAICS code is 1129 and its SIC code is 2011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Perishable NewsEver After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat ProductivityEver After Foods and Roslin Technologies announced joint cultivated meat production results, combining Roslin's cell platform with Ever After's Edible Packed Bed technology. The platform achieved cell density above 150 million cells/ml and volumetric productivities of 326gr/L wet biomass, 57gr/L dry biomass, and 40gr/L cultivated protein, 19 times higher than stirred-tank suspension benchmark. The companies are now advancing development and scale-up work.vegconomistEver After Foods and Roslin Technologies Report 19-Fold Rise in Cultivated Pork Protein OutputEver After Foods and Roslin Technologies reported a 19-fold increase in cultivated pork protein by growing pig cells on a plant-based scaffold instead of in a conventional bioreactor. The scaffold makes up less than 2% of the product by weight, and each cell produced about four times more protein.GlobeNewswireEver After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat ProductivityEver After Foods and Roslin Technologies announced joint cultivated meat production results, combining Roslin's cell platform with Ever After's Edible Packed Bed technology. The platform achieved cell density above 150 million cells/ml and volumetric productivities of 326gr/L wet biomass, 57gr/L dry biomass, and 40gr/L cultivated protein, representing 19 times higher dry biomass and 11 times higher wet biomass productivity versus a stirred-tank benchmark. The companies are now advancing development and scale-up work.EuroweeklynewsLab-Grown Meat:Coming soon to UK supermarkets?The UK's Food Standards Agency launched a regulatory programme to fast-track approval of cell-cultivated products, with no lab-grown food currently legally available for human consumption. The UK was the first European country to approve cultivated meat for pet food, and companies like Hoxton Farms and Roslin Technologies are preparing for human consumption. If approved, the UK could become a global leader in sustainable food production.TNGlobalRevolutionizing the Philippines' food industry: Unleashing innovation and technologyThe Philippines faces food security challenges, with nearly 12% of families experiencing involuntary hunger and high retail prices. Kickstart Ventures, backed by Ayala Corporation, is investing in foodtech startups like Roslin Technologies and SariSuki to address these issues. The article highlights the potential of technology to reduce waste and improve supply chains.iGrow NewsRoslin Technologies Partners with Kickstart Ventures to Lead in Global Cultivated Meat IndustryEdinburgh-based Roslin Technologies has secured investment from Kickstart Ventures through the Ayala Corporation Technology Innovation Venture Fund to expand its global cultivated meat industry operations. This strategic partnership aims to strengthen Roslin's presence in Asia and support its mission of providing animal cell lines for cultivated meat production. The investment highlights growing interest in alternative protein solutions to address global food security challenges.EdRoslin Tech announces further investmentRoslin Technologies, a spinout from the University of Edinburgh, has secured further investment led by Philippine-based Kickstart Ventures through its ACTIVE Fund. This strategic funding follows the company's previous £11m Series A round and aims to strengthen its market footprint in Asia, where it currently supplies animal cell lines for the cultivated meat industry. The investment expands Roslin Technologies' international shareholder base and supports its goal of expanding operations beyond its existing customers in North America and Europe.BBCWould you switch your dog to eating lab-grown meat?Good Dog Food, a joint venture of Agronomics and Roslin Technologies, is developing lab-grown chicken for pets, aiming to market it within a few years. The company claims the process uses less land, water, and electricity, and avoids antibiotics. The article also notes the pet food industry's large environmental footprint and growing interest in sustainable alternatives.BBCWould you switch your dog to eating lab-grown meat?Good Dog Food, a joint venture between Agronomics and Roslin Technologies, is developing lab-grown meat for pets to address the environmental impact of the pet food industry. The company aims to bring cultivated chicken products to market within the next few years as a sustainable alternative to conventional meat.GlobalaginvestingNovo Holdings Leads £11M Series A for Roslin Tech to Scale Cell Biomass for Meat ProductionRoslin Tech closed an £11 million Series A led by Novo Holdings, with participation from Kairos Capital, Nutreco, and others. The funding will expand its cell line portfolio and develop protocols for scale-up into cost-competitive biomass for cultivated meat. The company also plans to invest in its insect venture.